Moderna (MRNA) Deferred Taxes (2021 - 2023)
Moderna (MRNA) posted quarterly Deferred Taxes of -$33.0 million for Q4 2023, up 68.57% year-over-year from -$19.6 million in Q4 2022, and down 102.25% on a QoQ basis from $1.5 billion in Q3 2023.
Moderna (MRNA) Deferred Taxes (2021 - 2023) Analysis & Trends
Moderna has reported Deferred Taxes for 3 years, with the latest figure at -$33.0 million in Q4 2023.
- Deferred Taxes for Q4 2023 came in at -$33.0 million, up 68.57% year-over-year; the trailing twelve-month figure through Sep 2024 was -$33.0 million (down 103.98% YoY), and the FY2023 annual result was $901.0 million, up 255.88% from the prior year.
- Deferred Taxes declined to -$33.0 million in Q4 2023, from $1.5 billion in the prior quarter.
- Over five years, Deferred Taxes peaked at $1.5 billion in Q3 2023 and troughed at -$310.0 million in Q1 2023.
- A 3-year average of $416666.7 and a median of -$101.0 million in 2022 frame the typical range for Deferred Taxes.
- The widest annual swing landed in 2022, when Deferred Taxes tumbled 945.45%; it then jumped 1609.28% in 2023.
- A 3-year view of Deferred Taxes shows it stood at -$229.0 million in 2021, then soared by 54.15% to -$105.0 million in 2022, then soared by 68.57% to -$33.0 million in 2023.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$33.0 million in Q4 2023, $1.5 billion in Q3 2023, and -$220.0 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Roivant Sciences | 26.20 Bn | 26.20 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -106.00 Mn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | -220.00 Mn |
| Mar 31, 2023 | -310.00 Mn |
| Dec 31, 2022 | -105.00 Mn |
| Sep 30, 2022 | -97.00 Mn |
| Jun 30, 2022 | -230.00 Mn |
| Mar 31, 2022 | -146.00 Mn |
| Dec 31, 2021 | -207.00 Mn |
| Sep 30, 2021 | -17.00 Mn |
| Jun 30, 2021 | -22.00 Mn |
| Mar 31, 2021 | -50.00 Mn |